Is the Reaction to MDMA-AT Giving Us PTSD?

A Guest Article by Alison McInnes, M.D.

Here is another very exciting guest post. More of these feel good, dear readers, in that the plural in The Frontier Psychiatrists' name? It always took other perspectives into account and imagined a variety of authors. Today, we welcome my friend Alison McInnes, M.D., a psychiatrist and pioneer in ketamine research. She works with

Carlene MacMillan, MD

, my wife, at Osmind. This column is a think—or maybe feel?— piece on the (soon-to-be decided) MDMA-AT FDA submission, with previous coverage on the topic available here:

Can MDMA-AT Be Saved, Part I

Can MDMA-AT Be Saved, Part II

Should MDMA-AT Be Saved, Part III

Saving MDMA from AT: Part IV

Bad Touch!: MDMA Part V

Saving MDMA (and other psychedelic therapies), Part VI

Saving MDMA VII: This Isn't The First Drug to Have Problems Getting Approved

Today’s article is from a doctor who’s thought about it more than most…